Intervention Protocol

Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test

  1. Esther van der Heijden1,
  2. Alberto D Lopes2,
  3. Andrew Bryant3,
  4. Ruud Bekkers1,
  5. Khadra Galaal2,*,
  6. Nagindra Das2

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 3 OCT 2013

DOI: 10.1002/14651858.CD010757


How to Cite

van der Heijden E, Lopes AD, Bryant A, Bekkers R, Galaal K, Das N. Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010757. DOI: 10.1002/14651858.CD010757.

Author Information

  1. 1

    Radboud University Nijmegen Medical Centre, Department of Gynaecology and Obstetrics, Nijmegen, Netherlands

  2. 2

    Princess Alexandra Wing, Royal Cornwall Hospital, Gynaecological Oncology, Truro, Cornwall, UK

  3. 3

    Newcastle University, Institute of Health & Society, Newcastle upon Tyne, UK

*Khadra Galaal, Gynaecological Oncology, Princess Alexandra Wing, Royal Cornwall Hospital, Treliske, Truro, Cornwall, TR1 3LJ, UK. Khadra.Galaal@rcht.cornwall.nhs.uk. khadragalaal@yahoo.co.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 3 OCT 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  • To evaluate the risk of developing recurrent cervical intraepithelial neoplasia 2+ (CIN2+) in women with a positive high risk human papilloma virus (HPV) test after large loop excision of the transformation zone (LLETZ) treatment
  • To determine the optimal follow-up strategies for women following LLETZ treatment according to high risk HPV status